MYC and P53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-Cell and Immunotherapy Responses in Prostate Cancer

Using innovative electroporation-based mouse models, scientists generated distinct genetic subtypes of CRPC found in patients and uncovered unique immune microenvironments.